Clinical Trial

High-Intensity Transcranial Alternating Current Stimulation (Hi-tACS) for Hypertension: A Randomized Controlled Trial

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study focuses on individuals with primary hypertension, with the main objective of investigating the effectiveness and safety of high-intensity transcranial alternating current stimulation (Hi-tACS) as a non-invasive, non-pharmacological treatment for hypertension
Trial Details
NCT Number NCT07566650
Lead Sponsor Xuanwu Hospital, Beijing
Conditions Primary Hypertension
Enrollment 50 participants
Start Date 2026-05-01
Primary Completion 2027-10-01 (estimated)
Study Completion 2028-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-05